Ann E. Bolton - Concepedia

Author

Ann E. Bolton

Also Known As

A. E. Bolton, Ann E. Bolton

Publications

Citations

H-Index

Concepts

All Affiliations

Ann E. Bolton is an author at Novartis (Switzerland) specializing in clinical pharmacology, drug resistance, and pharmacotherapy.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	156
2	Pharmacology	1	1	156
3	Clinical Pharmacology	1	1	156
4	Drug Resistance	1	1	156
5	Pharmacokinetics	1	1	156

Ann E. Bolton

Publications

Citations

H-Index

Page 1

	Year	Citations
Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Stephen G. O’Brien, François Guilhot, Richard A. Larson, New England Journal of Medicine	2003	3.5K
Frequency of Major Molecular Responses to Imatinib or Interferon Alfa plus Cytarabine in Newly Diagnosed Chronic Myeloid Leukemia Timothy P. Hughes, Jaspal Kaeda, Susan Branford, New England Journal of Medicine	2003	1.2K
Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects Ann E. Bolton, Bin Peng, Martine Hubert, Cancer Chemotherapy and Pharmacology Healthy SubjectsImatinib MesylatePharmacological StudyPharmacologyClinical Pharmacology	2004	156
Population pharmacokinetics of imatinib mesylate in patients with chronic‐phase chronic myeloid leukaemia: results of a phase III study Heinz Schmidli, Bin Peng, G‐J. Riviere, British Journal of Clinical Pharmacology	2005	124

Page 1